期刊文献+

幽门螺杆菌根除失败患者耐药情况分析 被引量:3

An analysis of antibiotics resistance in patients with Helicobacter pylori eradication failure
原文传递
导出
摘要 目的分析幽门螺杆菌(HP)感染治疗失败患者的耐药情况,为HP感染补救治疗提供指导。方法经^(13)C呼气试验确诊HP治疗失败的门诊患者269例,行胃镜取胃窦小弯和胃体大弯黏膜标本进行培养。对HP培养阳性患者采用最低抑菌浓度试验药敏法分别行阿莫西林、克拉霉素、左氧氟沙星、甲硝唑、呋喃唑酮和四环素药敏试验。结果269例患者中,190例HP培养阳性,HP阳性率为70.63%。HP培养阳性患者中,甲硝唑耐药菌株率为97.37%,克拉霉素耐药菌株率为58.95%,左氧氟沙星耐药菌株率为48.42%,无阿莫西林、呋喃唑酮和四环素耐药菌株。二重耐药的总耐药菌株率为44.74%;其中,甲硝唑和克拉霉素耐药菌株率为47.06%,甲硝唑和左氧氟沙星耐药菌株率为47.06%,克拉霉素和左氧氟沙星耐药菌株率为5.88%。对甲硝唑、克拉霉素和左氧氟沙星三重耐药菌株率为32.11%。结论抗生素耐药是HP治疗失败的重要原因,了解耐药情况有助于选择补救治疗的个体化治疗方案,提高治疗的成功率。 Objective To analyze the antibiotics resistance in the patients with Helicobacter pylori(HP)eradication failure for providing a guidance in remedy treatment.Methods HP culture of the biopsy samples from the gastrointestinal sinus small bend and gastric body large bend mucosa taken by gastroscopy was performed in 269 patients with HP eradication failure confirmed by carbon ^(13)C-urea breath test.The minimum inhibitory concentration test was used to test the resistance of the HP positive culture samples to amoxicillin,clarithromycin,levofloxacin,metronidazole,furazolidone and tetracycline.Results Of 269 patients with HP eradication failure,190 cases were with HP positive with a positive rate of 70.63% HP infection.In 190 patients with HP positive culture,the percentages of HP line with antibiotics resistance were 97.37%for metronidazole,58.95%for clarithromycin,and 48.42%for levofloxacin.There was no case with a resistance to amoxicillin,furazolidone or tetracycline.The overall percentage of HP line with a resistance to two antibiotic drugs was 44.74%.The percentages of HP line with a resistance to two antibiotic drugs were 47.06%for metronidazole and clarithromycin,47.06%for metronidazole and levofloxacin,and 5.88%for clarithromycin and levofloxacin.The percentage of HP line with a resistance to three antibiotic drugs of metronidazole,clarithromycin and levofloxacin was 32.11%.Conclusion Antibiotic resistance is an important cause of HP treatment failure,and understanding drug resistance can help to choose individualized treatment options for remedy treatment and improve the success rate of treatment.
作者 叶峰 陈涵 杨振 许丽娟 张国新 YE Feng;CHEN Han;YANG Zhen(Department of Gastroenterology,First Affiliated Hospital,Nanjing Medical University,Nanjiny 210029,CHINA)
出处 《江苏医药》 CAS 2021年第12期1267-1269,共3页 Jiangsu Medical Journal
基金 江苏省"六大人才高峰"资助项目(2018-WSW-003)。
关键词 幽门螺杆菌 耐药 抗生素药敏试验 Helicobacter pylori Drug resistance Antibiotics susceptibility test
  • 相关文献

参考文献5

二级参考文献46

  • 1Bin Lu Ming-Tao Chen Yi-Hong Fan Yan Liu Li-Na Meng.Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: A 3-year follow-up study[J].World Journal of Gastroenterology,2005,11(41):6518-6520. 被引量:27
  • 2曹勤,冉志华,萧树东.血清胃蛋白酶原、胃泌素-17和幽门螺杆菌IgG抗体筛查萎缩性胃炎和胃癌[J].胃肠病学,2006,11(7):388-394. 被引量:113
  • 3刘文忠,吕宝妹,萧树东,徐蔚文,施尧,张德中.含克拉霉素的短程三联疗法根除幽门螺杆菌[J].中华内科杂志,1996,35(12):803-806. 被引量:41
  • 4Catherine de Martel,Jacques Ferlay,Silvia Franceschi,Jér?me Vignat,Freddie Bray,David Forman,Martyn Plummer.Global burden of cancers attributable to infections in 2008: a review and synthetic analysis[J].Lancet Oncology.2012(6)
  • 5Wen Zhong Liu,Yong Xie,Hong Cheng,Nong Hua Lu,Fu Lian Hu,Wan Dai Zhang,Li Ya Zhou,Ye Chen,Zhi Rong Zeng,Chong Wen Wang,Shu Dong Xiao,Guo Zong Pan,Pin Jin Hu.Fourth C hinese National Consensus Report on the management of H elicobacter pylori infection[J].Journal of Digestive Diseases.2013(5)
  • 6Yuji Maehata,Shotaro Nakamura,Kiyoshi Fujisawa,Motohiro Esaki,Tomohiko Moriyama,Kouichi Asano,Yuta Fuyuno,Kan Yamaguchi,Issei Egashira,Hyonji Kim,Motonobu Kanda,Minako Hirahashi,Takayuki Matsumoto.Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer[J].Gastrointestinal Endoscopy.2012(1)
  • 7Vincenza Conteduca,Domenico Sansonno,Gianfranco Lauletta,Sabino Russi,Giuseppe Ingravallo,Franco Dammacco.H. pylori infection and gastric cancer: State of the art (Review)[J].International Journal of Oncology.2013(1)
  • 8MasahiroAsaka,MototsuguKato,Shin‐ichiTakahashi,YoshihiroFukuda,ToshiroSugiyama,HiroyoshiOta,NaomiUemura,KazunariMurakami,KiichiSatoh,KentaroSugano.Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition[J].Helicobacter.2010(1)
  • 9S.‐J. Cho,I. J. Choi,M.‐C. Kook,H. Yoon,S. Park,C. G. Kim,J. Y. Lee,J. H. Lee,K. W. Ryu,Y.‐W. Kim.Randomised clinical trial: the effects of H elicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer[J].Aliment Pharmacol Ther.2013(5)
  • 10Peter Malfertheiner,Michael Selgrad.Helicobacter pylori infection and current clinical areas of contention[J].Current Opinion in Gastroenterology.2010(6)

共引文献608

同被引文献38

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部